特此公告。 浙江争光实业股份有限公司董事会 2025 年 8 月 29 日 浙江争光实业股份有限公司 关于调整公司组织架构的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完 整，没有虚假记载、误导性陈述或重大遗漏。 浙江争光实业股份有限公司（以下简称"公司"）于 2025 年 8 月 27 日召开了第六届董事会第十六次会议，审议通过了《关于调整 公司组织架构的议案》。 为了进一步完善公司治理结构，满足公司实际业务管理需要，明 确职责划分，提高公司经营管理效率，根据有关法律法规、规范性文 件和《公司章程》的规定，董事会结合公司实际情况和未来发展规划， 对公司原组织架构进行了调整和优化，公司调整后的组织架构图详见 附件。 证券代码：301092 证券简称：争光股份 公告编号：2025-047 附件：浙江争光实业股份有限公司组织架构图 ...

证券代码：301092 证券简称：争光股份 公告编号：2025-042 浙江争光实业股份有限公司（以下简称"公司"）于 2025 年 8 月 27 日召开第六届董事会第十六次会议，审议通过了《关于<2025 年半年度报告>全文及其摘要的议案》。 浙江争光实业股份有限公司 2025 年半年度报告披露提示性公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完 整，没有虚假记载、误导性陈述或重大遗漏。 特此公告。 浙江争光实业股份有限公司董事会 2025 年 8 月 29 日 为使投资者全面了解公司 2025 年半年度的经营成果及财务状况， 公司《2025 年半年度报告》全文及《2025 年半年度报告摘要》于 2025 年 8 月 29 日在中国证券监督管理委员会指定的创业板信息披露网站 巨潮资讯网（www.cninfo.com.cn)上披露。 敬请广大投资者注意查阅。 ...

证券代码：301092 证券简称：争光股份 公告编号：2025-046 浙江争光实业股份有限公司 董事会关于募集资金 2025 年半年度存放、管理与使用情况的专项报 告 为了规范募集资金的管理和使用，提高资金使用效率和效益，保护投资者权益，本公司 按照《中华人民共和国公司法》《中华人民共和国证券法》《上市公司募集资金监管规则》和 《深圳证券交易所上市公司自律监管指引第2号——创业板上市公司规范运作》等有关法律、 法规和规范性文件的规定，结合公司实际情况，制定了《浙江争光实业股份有限公司募集资 金管理办法》（以下简称《管理办法》）。根据《管理办法》，本公司对募集资金实行专户存储， 在银行设立募集资金专户，并连同保荐机构国信证券股份有限公司于2021年10月26日与杭州 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 根据中国证券监督管理委员会《上市公司募集资金监管规则》和《深圳证券交易所上市 公司自律监管指引第 2 号——创业板上市公司规范运作》的规定，将本公司募集资金 2025 年半年度存放与使用情况专项说明如下： 一、募集资金基本情况 (一) 实际募集资金金 ...

2025年半年度非经营性资金占用及其他关联资金往来情况汇总表 浙江争光实业股份有限公司 编制单位：浙江争光实业股份有限公司 单位：人民币万元 法定代表人： 沈建华 主管会计工作的负责人：吴雅飞 会计机构负责人：吴雅飞 | 非经营性资金占用 | 资金占用方名称 | 占用方与上市公司 的关联关系 | 上市公司核算的会 计科目 | 2025年期初 占用资金余额 | 2025年半年度占用 累计发生金额 | 2025年半年度占 用资金的利息 | 2025年半年度偿 还累计发生金额 | 2025年半年期末 占用资金余额 | 占用形成原因 | 占用性质 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | | | | （不含利息） | （如有） | | | | | | 控股股东、实际控制人及其附 | | | | | | | | | | 非经营性占用 | | 属企业 | | | | | | | | | | 非经营性占用 | | 小 计 | - | - | - | | | | | | | - | | 前控股股东、实际控制人及其 | ...

Financial Performance - The company's operating revenue for the first half of 2025 was RMB 326,892,022.69, representing a 22.37% increase compared to RMB 267,124,891.81 in the same period last year[20]. - The net profit attributable to shareholders of the listed company was RMB 53,380,178.73, a slight increase of 1.48% from RMB 52,601,543.55 in the previous year[20]. - The net profit after deducting non-recurring gains and losses was RMB 49,564,606.95, which is a 17.01% increase from RMB 42,358,532.96 in the same period last year[20]. - The net cash flow from operating activities decreased by 40.97% to RMB 24,559,568.59, down from RMB 41,605,686.76 in the previous year[20]. - The total assets at the end of the reporting period were RMB 2,172,361,295.74, a decrease of 1.72% from RMB 2,210,322,450.41 at the end of the previous year[20]. - The net assets attributable to shareholders of the listed company increased by 1.13% to RMB 1,907,273,899.81 from RMB 1,886,045,107.20 at the end of the previous year[20]. - Basic and diluted earnings per share were both RMB 0.40, reflecting a 2.56% increase from RMB 0.39 in the same period last year[20]. - The weighted average return on equity decreased to 2.81% from 3.36% in the previous year, a decline of 0.55%[20]. Research and Development - As of June 30, 2025, the company has 81 technical R&D personnel, representing 18.37% of total employees, and has been recognized as a "Provincial High-tech Enterprise R&D Center" by the Zhejiang Provincial Department of Science and Technology[29]. - The company holds 22 valid patents, including 14 invention patents and 8 utility model patents, as of June 30, 2025[30]. - The company has established a research and development team of 81 personnel, with 22 patents, and collaborates with universities to drive innovation in resin technology[43]. - The company is focusing on the biopharmaceutical market, anticipating that the domestic biopharmaceutical market will exceed 1 trillion yuan by 2030, with plans to develop high-value products[40]. Market Position and Strategy - The company specializes in the research, production, and sales of ion exchange and adsorption resins, achieving significant market presence both domestically and internationally, with clients including major corporations like BRITA and Mitsubishi Chemical[28]. - The company aims to break the technological monopoly of developed countries and contribute to domestic substitution efforts in the future[29]. - The downstream demand for ion exchange and adsorption resins is expected to grow, driven by industries such as power generation, petrochemicals, and emerging sectors like biomedicine and new energy[35]. - The company has plans to enhance its R&D capabilities and expand its product applications to meet the evolving needs of various industries[29]. - The company is expanding its presence in the renewable energy market, focusing on lithium adsorption materials and battery recycling, aiming for mass production soon[39]. - The company aims to increase its market share in the high-end water treatment sector, focusing on high-capacity resin for condensate water treatment, which constitutes 90% of boiler feed water[41]. Financial Management - The company reported a total of RMB 3,815,571.78 in non-recurring gains and losses during the reporting period[24]. - The company has committed to a project with an annual processing capacity of 15,000 tons of food-grade resin, expected to achieve a net profit of 869.65 million yuan annually after reaching full production by 2025[66]. - The company is developing a large-pore adsorption resin technology with a planned annual output of 2,300 tons, projected to generate an annual net profit of 1,392.61 million yuan by the first half of 2025[67]. - The company has invested RMB 240 million in cash management products, with RMB 15 million remaining unredeemed as of June 30, 2025[69]. - The company has not engaged in any significant equity or non-equity investments during the reporting period[61]. Operational Challenges - The company faced significant raw material price fluctuation risks, with costs heavily influenced by the prices of styrene and divinylbenzene, which are closely tied to crude oil prices[78]. - To mitigate raw material cost increases, the company plans to sign procurement contracts in advance and adjust product prices in response to significant raw material price hikes[79]. - The company is experiencing intensified market competition, which may lead to a reduction in market share if new high-value products are not developed[79]. - The company has experienced increased production costs due to rising raw material prices, impacting profit margins[67]. Corporate Governance and Social Responsibility - The company adheres to legal requirements for corporate governance and has established a sound internal management system to protect shareholder rights[94]. - The company actively participates in charitable activities, including donations to support children in need and initiatives for poverty alleviation and rural revitalization[93]. - The company has established a disability employment assistance base, helping four disabled individuals find employment[93]. - The company has implemented various employee welfare measures, including training programs to enhance employee skills and career development[95]. Shareholder Information - The company has not planned to distribute cash dividends or issue new shares from capital reserves for the semi-annual period[85]. - The company approved the use of up to RMB 600 million of idle raised funds and self-owned funds for cash management, effective for 12 months from the shareholder meeting[69]. - The total number of restricted shares before the change was 90,873,600, accounting for 67.79% of the total shares, which decreased to 73,798,700 shares, representing 55.05% after the change[122]. - The largest shareholder, Shen Jianhua, holds 51.83% of shares, totaling 69,480,000 shares[130]. Financial Reporting and Compliance - The financial statements are prepared based on the assumption of going concern, with no significant doubts regarding the company's ability to continue operations in the next 12 months[172]. - The accounting policies adhere to the enterprise accounting standards, ensuring a true and complete reflection of the company's financial status and operating results[174]. - The company’s financial statements reflect a commitment to transparency and compliance with relevant accounting standards, ensuring stakeholders have access to accurate financial information[174].

第六届董事会第十六次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完 整，没有虚假记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 浙江争光实业股份有限公司（以下简称"公司"）第六届董事会 第十六次会议通知于 2025 年 8 月 15 日以电子邮件的方式送达至全体 董事。本次会议于 2025 年 8 月 27 日在公司会议室以现场结合通讯方 式召开。会议应出席董事 7 人，实际出席董事 7 人，其中董事劳法勇， 独立董事冯凤琴、肖连生、金浪以通讯方式出席会议。本次会议由董 事长沈建华先生召集并主持，公司高级管理人员列席了本次董事会。 本次会议的召集、召开和表决程序符合《中华人民共和国公司法》等 法律法规和《公司章程》的有关规定，会议合法、有效。 二、董事会会议审议情况 会议审议并通过了如下议案： 证券代码：301092 证券简称：争光股份 公告编号：2025-043 浙江争光实业股份有限公司 1、审议通过《关于<2025 年半年度报告>全文及其摘要的议案》 全体与会董事认真审议了公司《2025年半年度报告》全文及其摘 要，认为公司《2025年半年度报告》真实、准确、完整地反映了公司 ...

（文章来源：证券日报） 证券日报网讯争光股份8月22日在互动平台回答投资者提问时表示，根据中国结算深圳分公司的最新数 据，截至2025年8月20日，公司股东户数为10292户。 ...

Core Viewpoint - Zhangguang Co., Ltd. (301092.SZ) experienced a stock price decline of 5.45%, closing at 31.94 yuan, indicating that the stock is currently in a state of underperformance [1] Group 1: Company Overview - Zhangguang Co., Ltd. was listed on the Shenzhen Stock Exchange's Growth Enterprise Market on November 2, 2021, with a total issuance of 33.33334 million shares, accounting for 25.00% of the post-issue total share capital [1] - The initial public offering (IPO) price was set at 36.31 yuan per share, with Guosen Securities Co., Ltd. serving as the sponsor [1] Group 2: Fundraising and Financials - The total amount raised from the IPO was 1.21 billion yuan, with a net amount of 1.10 billion yuan, exceeding the original fundraising plan by 723 million yuan [1] - The funds raised are intended for several projects, including a production line for 15,000 tons of food-grade resin, a technical upgrade for a 2,300-ton macroporous adsorption resin project, automation upgrades, and the establishment of a research center for ion exchange resin technology [1] - The total issuance costs for the IPO were 110 million yuan, with Guosen Securities receiving 86.723 million yuan as sponsorship and underwriting fees [1]

证券日报网讯 争光股份（301092）8月20日在互动平台回答投资者提问时表示，湖北荆门一期3.9万吨功 能性高分子新材料项目目前正在抓紧建设当中，预计2025年年底开始调试试生产，2026年4月底前达到 预定可使用状态，最终以实际开展为准。 ...

（文章来源：每日经济新闻） 每经AI快讯，有投资者在投资者互动平台提问：请问荆门工厂开始生产了吗？当前产能到达多少了？ 争光股份（301092.SZ）8月20日在投资者互动平台表示，湖北荆门一期3.9万吨功能性高分子新材料项 目目前正在抓紧建设当中，预计2025年年底开始调试试生产，2026年4月底前达到预定可使用状态，最 终以实际开展为准。 ...